Form 8-K - Current report:
SEC Accession No. 0000950170-24-135612
Filing Date
2024-12-12
Accepted
2024-12-12 09:09:24
Documents
19
Period of Report
2024-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kant-20241211.htm   iXBRL 8-K 115892
2 EX-2.1 kant-ex2_1.htm EX-2.1 923670
3 EX-10.1 kant-ex10_1.htm EX-10.1 199393
4 EX-10.2 kant-ex10_2.htm EX-10.2 105800
5 EX-10.3 kant-ex10_3.htm EX-10.3 119777
6 EX-10.4 kant-ex10_4.htm EX-10.4 79115
7 EX-99.1 kant-ex99_1.htm EX-99.1 60743
8 GRAPHIC img118959689_0.jpg GRAPHIC 123916
9 GRAPHIC img118959689_1.jpg GRAPHIC 9105
  Complete submission text file 0000950170-24-135612.txt   2006919

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kant-20241211.xsd EX-101.SCH 30886
22 EXTRACTED XBRL INSTANCE DOCUMENT kant-20241211_htm.xml XML 4534
Mailing Address 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040
Business Address 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040 (206) 378-0400
KINETA, INC./DE (Filer) CIK: 0001445283 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 241543373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)